ICD-10-CM Billable Code

H95.03

Recurrent cholesteatoma of postmastoidectomy cavity, bilateral ears

Clinical Classification Guidelines

Medical Intelligence & Overview

Recurrent cholesteatoma of the postmastoidectomy cavity is a condition characterized by the ongoing presence or return of a growth called cholesteatoma in the area where a mastoidectomy has been performed. Mastoidectomy is a surgical procedure to remove diseased mastoid air cells, often due to chronic ear infections. When cholesteatoma reappears in this area, especially in both ears, it can pose significant challenges due to its potential to damage nearby structures like the bones of the skull and the inner ear. Understanding this condition helps in recognizing its implications and seeking timely medical consultation.

Causes & Symptoms

Clinical Causes: Residual cholesteatoma tissue left behind during initial surgery that later proliferates again. Incomplete removal of cholesteatoma during previous mastoidectomy procedures. Recurrent infections or persistent chronic otitis media leading to scar tissue and renewed cholesteatoma growth. Eustachian tube dysfunction contributing to abnormal middle ear pressure and promoting cholesteatoma development. Anatomical variations or surgical challenges that increase the risk of incomplete disease eradication.

Key Symptoms: Persistent or recurrent foul-smelling ear discharge (otorrhea). Hearing loss, which gradually worsens over time. Ear fullness or pressure sensations. Possible discomfort or pain in the affected ears. Dizziness or balance issues in some cases, especially if inner ear structures are affected. Tinnitus, or ringing in the ears. Visible skin debris or a whitish mass behind the eardrum in some instances.

Diagnostic & Treatment

Diagnosis Path: Diagnosing recurrent cholesteatoma involves a combination of clinical evaluation and diagnostic procedures. An otolaryngologist (ear, nose, and throat specialist) will perform a thorough ear examination, often using an otoscope to visualize the middle ear and postmastoidectomy cavity. Additional diagnostic tools include imaging studies such as high-resolution computed tomography (CT) scans to identify cholesteatoma tissue, its extent, and any associated bone destruction. Sometimes, an MRI may be used for further assessment, especially when the diagnosis is uncertain or there is concern about complications.

Treatment Protocols: Treatment typically involves surgical intervention aimed at removing the cholesteatoma and preventing further damage. Depending on the severity and recurrence, options include revision mastoidectomy procedures. The goals of surgery are complete removal of the cholesteatoma, preservation of hearing when possible, and restoration of the normal anatomy of the middle ear and mastoid cavity. Postoperative care involves regular follow-up appointments, imaging studies, and hearing assessments to monitor for any signs of recurrence. In some cases, audiological rehabilitation such as hearing aids may be recommended if significant hearing loss persists.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H95.03 a billable ICD-10 code?
Yes, H95.03 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H95.03?
Clinical documentation must specify the nature of Recurrent cholesteatoma of postmastoidectomy cavity, bilateral ears and any associated comorbidities for accurate reporting.

Cite this Clinical Reference